Climedo

Climedo offers an all-in-one eCOA and EDC solution with hybrid capabilities for non-interventional studies and real-world evidence. By using a patient-centric approach and leveraging real-time data insights and visualizations around a studys current progress, Climedo empowers its clients to better engage with healthcare professionals and other key opinion leaders (KOLs). This boosts awareness, stimulates scientific dialogue and accelerates the launch success of new medical innovations, thus reaching more patients faster. Founded in Munich in 2017, Climedo is a leading trusted partner for pharma, medtech, CROs and academia with over 1.7 million patients enrolled to date

Digital healthcare,big data,analytics,medical research,software,saas,clinical validation,electronic data capture,epro,esurveys,clinical trials,clinical data,data reporting,pharma,biotech,cros,hospitals & academia,health offices,medtech,commercialization,market access,ecoa,scientific dialogue,medicomarketing,phase iv trials,post-market trials,post-approval studies,kol engagement,data to dialogue,interactive dashboards,patient centricity,real-world evidence,and real-time data insights

Climedo operates in the Information technology & services industry.

Climedo's revenue is 11m - 100m

Climedo has 11 - 50 employees.